Innovating Clinical Trials
Welcome to Innovating Clinical Trials, the podcast designed for clinical research professionals eager to deepen their understanding of clinical trials through concise, insightful segments. Join your hosts, Liam Eves and Ted Trafford, as they uncover the core issues in clinical research, reflect on the industry, and challenge conventional wisdom.
Ted Trafford - https://probitymedical.com/
With 30 years of experience in clinical research, Ted serves as the Director of Business Development, driving business growth and leading Feasibility and Site Relationship teams at Probity Medical Research, a clinical trial site administrative support company with a consortium of 75+ sites across four countries. As a writer and speaker, Ted contributes to thought leadership and strategic initiatives in the clinical trials industry, leveraging his extensive experience and creative approach to drive meaningful discussion and progress for Sponsors, CROs, Sites and Technology Vendors.
Liam Eves - https://www.theendpointpodcast.com/
Liam's held executive roles in SMOs and CROs, and led all major functions of trial delivery. His journey into the field began unexpectedly after an injury ended his career as a professional footballer. Over the years Liam has optimized trial delivery methods / systems for effective enrollment and trial delivery. Currently, he focuses on building and advising companies in the clinical trial space.
Opinions expressed are those of the participants and not their employers.
Innovating Clinical Trials
Latest Episodes
ICT Ep 2.43: Robert Goldman on AI in Clinical Operations: Innovation or Marketing? (Part 3/3)
In Part 3 of this three-part conversation, Liam and Ted wrap up their discussion with Robert Goldman, Vice President and Global Head of Clinical Operations at Contraline, on a question that lands in every ClinOps inbox: is “AI-powered” innovati...
ICT Ep 2.42: Robert Goldman on Rethinking Feasibility (Part 2/3)
In Part 2 of this three-part conversation, Liam and Ted continue their discussion with Robert Goldman, Vice President and Global Head of Clinical Operations at Contraline, to talk about why feasibility so often fails to predict what happens nex...
ICT Ep 2.41: Robert Goldman on "Optimism Is Not an Enrollment Plan" (Part 1/3)
In Part 1 of this three-part conversation, Liam and Ted sit down with Robert Goldman, Vice President and Global Head of Clinical Operations at Contraline, who brings nearly 20 years of clinical research experience spanning CRO roles and sponsor...
ICT Ep 2.40: Duncan Shaw on the AI Translation Trap: Why the Human “Last Mile” Still Matters When the Stakes Are High (Part 3/3)
In Part 3 of this three-part conversation, Liam and Ted wrap up their discussion with Duncan, President at DTS Language Services about AI, risk mitigation, and the human factors that are hard to capture in clinical trial translation.Dun...
ICT Ep 2.39: Duncan Shaw on the Translation “Quilt Factor”: How Inconsistency Can Erode Patient Trust and Derail Trial Operations (Part 2/3)
In Part 2 of this three-part conversation, Liam and Ted continue their discussion with Duncan, President at DTS Language Services about patient trust, consistency, and the operational realities of translating clinical trial content.